U.S., India Navigate Uncertainties Amidst Upcoming Pharma Tariffs

July 18, 2025--Researched by Industrial Info Resources (Sugar Land, Texas)--In the dynamic landscape of trade tensions, the U.S. is likely to unveil another set of import duties. In an effort to reduce reliance on foreign nations for pharma products, foster fair trade, boost domestic production and encourage reshoring, the country is set to introduce import tariffs targeting the Pharmaceutical-Biotech Industry. After signaling for months through statements like 'major pharma tariffs coming soon' and pharma import investigations under Section 232, U.S. President Donald Trump recently hinted on a figure saying "a very, very high rate, like 200%." Although no formal announcements have been made, concerns regarding impending tariffs have been mounting globally.